A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients

NCT04101383 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Clamp Study

Interventions

DRUG: RinGlar®
DRUG: Lantus®

Sponsor

Geropharm